rs72613567T>TA in HSD17B13 was protective against the diagnosis of NAFLD (OR, 0.71; 95% CI, 0.58–0.86), and no association with the diagnosis of NAFLD was observed with rs2642438G>A in MTARC1 (Table S1). Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.